Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Forecasted Growth Rate and Market Size of the Anti-Inflammatory Drugs Market?

The market size for anti-inflammatory drugs has seen a fast-paced growth lately. From $136.86 billion in 2024, the market is anticipated to expand to $152.08 billion in 2025, achieving a compound annual growth rate (CAGR) of 11.1%. The rapid growth seen in history can be associated with several factors including a growing senior population, a rising occurrence of chronic inflammation-related diseases, an increase in over-the-counter accessibility, heightened recognition of pain management, and the growth of overall healthcare infrastructure.

The market for anti-inflammatory drugs is anticipated to experience substantial expansion in the coming years, reaching $228.83 billion by 2029 with a compound annual growth rate (CAGR) of 10.8%. The anticipated growth during this forecast period is attributed to factors such as the rising prevalence of autoimmune diseases, an increasing demand for individualized medicine, a growing elderly population, supportive governmental initiatives, and an increased preference for topical and targeted treatments. Future trends expected to impact the market during this period include innovations in biologic drugs, a shift towards biologics and biosimilars, telemedicine prescriptions, AI integration in drug discovery, research and development in new anti-inflammatory mechanisms, and advancements in targeted anti-inflammatory therapies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24465&type=smp

Which Factor Is Shaping The Future Of The Anti-Inflammatory Drugs Market?

The growth of the anti-inflammatory drugs market is expected to be stimulated by the rising prevalence of arthritis. Arthritis includes the inflammation of one or more joints, which can lead to pain, swelling, and stiffness that often intensifies with age. This increase in arthritis cases is primarily associated with an aging population since as people grow older, they naturally experience more wear and tear on their joints, which increases the risk of arthritis. Anti-inflammatory medications are crucial in addressing arthritis as they lessen joint inflammation and pain, improving patients’ mobility and making daily activities easier, thereby enhancing their overall life quality. For example, the Office for Health Improvement and Disparities, a UK-based government department, released data in March 2023 stating that in 2022, 17.6% of people aged 16 and above reported long-term musculoskeletal (MSK) conditions like arthritis or continuous back or joint problems. This was an increase from 17.0% in 2021. Consequently, the increasing occurrence of arthritis is fuelling the expansion of the anti-inflammatory drugs market.

What Is The Segment-Wise Breakdown Of The Anti-Inflammatory Drugs Market?

The anti-inflammatory drugs market covered in this report is segmented –

1) By Drug Class: Steroids, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Biologics And Biosimilars, Other Drug Classes

2) By Route of Administration: Parenteral, Oral, Topical, Inhalation

3) By Applications: Autoimmune Diseases, Respiratory Diseases, Other Diseases

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Steroids: Corticosteroids, Mineralocorticoids

2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Non-Selective Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Selective Cyclooxygenase-2 (COX-2) Inhibitors

3) By Biologics And Biosimilars: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin (IL) Inhibitors, Janus Kinase (JAK) Inhibitors, Other Biologics And Biosimilars

4) By Other Drug Classes: Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants, Antihistamines

Which Trends Are Redefining The Future Landscape Of The Anti-Inflammatory Drugs Industry?

The focus has shifted towards the creation of groundbreaking topical solutions within the anti-inflammatory drugs market, with numerous prominent firms endeavoring to enhance targeted delivery and patient adherence. A topical solution, which is a liquid-based medication applied right to the skin or affected region, streamlines the delivery of active elements of the anti-inflammatory drugs, reducing inflammation on-site while limiting the systemic side effects. In an illustrative case in December 2022, Lupin Limited, an Indian pharmaceutical firm, launched the authorized generic equivalent of PENNSAID (Diclofenac Sodium Topical Solution, 2% w/w) manufactured by Horizon Pharma Therapeutics, in the United States. This was aimed at boosting its U.S. generic range and augmenting the availability of reasonably priced anti-inflammatory remedies. This non-steroidal anti-inflammatory drug, meant to alleviate osteoarthritis-related knee pain, affords localized relief upon topical application and circumscribes systemic complications commonplace with orally administered NSAIDs.

Which Companies Hold The Largest Market Share In The Anti-Inflammatory Drugs Sector?

Major companies operating in the anti-inflammatory drugs market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Gilead Sciences Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories, Cipla Limited, Cadila Pharmaceuticals, Samsung Bioepis, Lupin Limited

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-drugs-global-market-report

How Does Regional Performance Compare Across The Anti-Inflammatory Drugs Industry?

North America was the largest region in the anti-inflammatory drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24465&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model